| Dr Mary Min-chin Lee, MD | |
|
55 Lake Ave N, Department Of Pediatric Endocrinology, Worcester, MA 01655 | |
| (508) 856-4280 | |
| (508) 856-4287 |
| Full Name | Dr Mary Min-chin Lee |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 55 Lake Ave N, Worcester, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225011349 | NPI | - | NPPES |
| 110049041A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 70464 (Massachusetts) | Secondary |
| 208000000X | Pediatrics | C1-0012649 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Min-chin Lee, MD Po Box 191, Rockland, DE 19732-0191 Ph: (302) 651-4945 | Dr Mary Min-chin Lee, MD 55 Lake Ave N, Department Of Pediatric Endocrinology, Worcester, MA 01655 Ph: (508) 856-4280 |
News Archive
A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal Vaccine.
Contrary to what might be expected, people who sustain a jaw fracture and lose consciousness actually tend to have milder bone injuries than those who do not black out from a trauma to the jaw, according to a study published in the Journal of Oral and Maxillofacial Surgery.
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Exhaust fumes heighten the risk of asthma in children who are already genetically susceptible to respiratory disease, indicates research published ahead of print in the journal Thorax.
ViroPharma Incorporated today announced that it has entered into an exclusive option to acquire Meritage Pharma, Inc., a private company based in San Diego, CA focused on developing oral budesonide suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus.
› Verified 8 days ago
Marissa E Parrillo, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-442-5545 Fax: 774-443-7042 | |
Dr. Penny M. Feldman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8081 Fax: 774-441-8055 | |
Dr. Linda D Sagor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-856-4198 Fax: 508-856-1042 | |
Dr. Robert W Zavoski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 Queen Street, Worcester, MA 01610 Phone: 508-860-7800 Fax: 508-860-7925 | |
Cornelius T Tyrrell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-334-7986 Fax: 508-334-7989 | |
Callie M Stone, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Nura El-haj, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8083 Fax: 774-441-8057 |